- Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis…
Number of the records: 1  

Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial

  1. TitlePaclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial / Mego M. ... [et al.]
    Another responsib. Mego, Michal (Bibliographic antecedent)
    Rejleková, Katarína (Bibliographic antecedent)
    Světlovská, Daniela (Bibliographic antecedent)
    Miškovská, Věra (Bibliographic antecedent)
    Kalavská, Katarína (Bibliographic antecedent)
    Obertová, Jana (Bibliographic antecedent)
    Palacka, Patrik (Bibliographic antecedent)
    Rečková, Mária (Bibliographic antecedent)
    Syčová-Milá, Zuzana (Bibliographic antecedent)
    Pinďák, Daniel (Bibliographic antecedent)
    Chovanec, Michal (Bibliographic antecedent)
    Mardiak, Jozef (Bibliographic antecedent)
    Redakcia Onkológia (Adapter)
    NoteEuropean Urology Open Science, vol. 33, November (2021), s. 19-27
    In Onkológia. -- ISSN 1336-8176. -- Roč. 16, č. 5 (2021), s. 391
    Call numberC 3069
    MeSH Subject nádory z germinatívnych a embryonálnych buniek - farmakoterapia
    paklitaxel
    ifosfamid
    cisplatina
    výsledok liečby
    skúšanie klinické, fáza II, ako téma
    Form, Genre abstrakt v angličtine
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.